Affordable and Safe Prescription Drug Importation Act of 2025

This bill would let pharmacies, drug wholesalers, and people import certain prescription medicines from Canada, the United Kingdom, countries in the European Union, and Switzerland, under strong safety rules . The Department of Health and Human Services must set up the program within one year. People could order up to a 90‑day supply for personal use, with a valid U.S. prescription, from certified foreign pharmacies (including online), and the government would post a public list of approved sellers . To protect patients, the health department can approve labs to test imported drugs, require reports from importers, and quickly suspend importation if there are safety problems . The bill also adds tough penalties for illegal online sales and blocks drugmakers from overcharging or limiting supply to stop legal imports . It is driven by findings that U.S. drug prices are far higher than in other countries and that many people skip needed medicines because of cost.

• Who is affected: patients buying for personal use; retail pharmacies and drug wholesalers that import; certified foreign pharmacies and distributors abroad; drug manufacturers; and online sellers that break the rules .
• What changes: imports allowed from Canada, the United Kingdom, EU countries, and Switzerland; individuals can buy up to a 90‑day supply with a valid U.S. prescription; a public list of approved foreign sellers; lab testing, importer reports and tracing information available to patients on request; fast suspensions if safety issues arise; penalties for illegal online sales; and rules to stop drugmakers from blocking legal imports .
• When: rules must be issued within 1 year; after the rules are final, imports may expand to more countries after 1 year if the first phase is shown to be safe; the health department must report on the program after 1 year and every 2 years, and the Government Accountability Office must report after 18 months .